Ursolic Acid

熊果酸

Report date: 2025/11/11 20:00:28
NME

Base Information

Drug NameUrsolic Acid
Drug Alias Name乌苏酸乌索酸NSC-167406NSC-4060
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 stimulants
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsMetabolic SyndromeInsulin ResistanceQuadriplegia +[17] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUniversity Of Guadalajara
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MiamiWuhan Liyuanheng Pharmaceutical Technology Co Ltd
Inactive CompaniesUT Health San AntonioThe University Of California DavisUniversity Of Guadalajara +[4] 
Active IndicationsInsulin ResistanceQuadriplegiaParaplegia +[9] 
Inactive IndicationsMetabolic SyndromeCholangitis, SclerosingProstatic Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG